SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-056577
Filing Date
2022-11-14
Accepted
2022-11-14 16:13:10
Documents
2
Period of Report
2022-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6188
2 POA DOCUMENT poa.txt EX-24 3094
  Complete submission text file 0001209191-22-056577.txt   10904
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HORIZON THERAPEUTICS PLC 70 ST. STEPHEN'S GREEN DUBLIN L2 D02 E2X4
Business Address
McIlvenny Patrick (Reporting) CIK: 0001952703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 221385428